BIORCHESTRA
Yusong
About BIORCHESTRA
BIORCHESTRA is a biotech company that develops RNA-based therapeutics for treating neuroinflammatory diseases. They focus on changing the therapeutic paradigm from treating the symptoms to providing a fundamental cure for diseases. BIORCHESTRA develops neuroinflammatory disease therapeutics, with a particular emphasis on comprehensive patient care. BIORCHESTRA's complementary discovery platforms range from diagnosis to treatment monitoring.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $60.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2022)
- Website: biorchestra.com
- Phone: 042-863-1013
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biorchestra-84267 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.